Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BAY 2416964 is a potent and orally active aryl hydrocarbon receptor (AHR) antagonist(example 192, IC50: 341 nM). It has the potential for cancer treatment.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 48.00 | |
2 mg | In stock | $ 68.00 | |
5 mg | In stock | $ 97.00 | |
10 mg | In stock | $ 169.00 | |
25 mg | In stock | $ 345.00 | |
50 mg | In stock | $ 497.00 | |
100 mg | In stock | $ 653.00 | |
200 mg | In stock | $ 929.00 | |
500 mg | In stock | $ 1,390.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 117.00 |
Description | BAY 2416964 is a potent and orally active aryl hydrocarbon receptor (AHR) antagonist(example 192, IC50: 341 nM). It has the potential for cancer treatment. |
Targets&IC50 | AhR:341 nM |
In vitro | BAY 2416964 induces AHR-regulated gene CYP1A1 expression in human monocytic U937 cells (IC50: 4.3 nM). |
Molecular Weight | 387.82 |
Formula | C18H18ClN5O3 |
CAS No. | 2242464-44-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 250 mg/mL (644.63 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BAY 2416964 2242464-44-2 Immunology/Inflammation Aryl Hydrocarbon Receptor inhibit CYP1A1 Inhibitor AhR anti-cancer BAY-2416964 BAY2416964 inhibitor